12/01/1997
https://www.congress.gov...
We should of course remain vigilant about pay-for-delay schemes, whereby branded drug manufacturers pay generic manufact...
Unfortunately, the current administration in swift fashion abandoned America's bipartisan leadership in this arena.
I am concerned that H.R. 2851 is a well-intentioned but flawed bill and raises several concerns.
Most prescription drugs save lives. Yet, it's also a fact that some result in injury and death.